CClinicalTrials.gg
Sign In
CompletedNCT02790424MAP-EFNI PVUpdated Nov 14, 2022

Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Patient Volunteers

An interventional study of Imaging devices in Neurological Diseases, sponsored by University Hospital, Grenoble. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-14.

Sponsored by University Hospital, Grenoble · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 2 years 6 months after the study started (first participant enrolled Oct 2013, registered May 2016).
Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Parameters, sequences or paradigms optimisation in view of data quality and relevancy improvement.

Read the detailed description

Various tests are needed for methodological optimization of the several devices (per-operative MRI, MEG, EEG, SPECT-CT, motor platform) of the technological platform.

02

Conditions studied

  • Neurological Diseases
03

In context

Nervous System Diseases

974 studies on the registry are indexed under Nervous System Diseases; 252 are open to participants now.

This study's enrollment of 35 is below the median of 48 across 623 interventional studies indexed under Nervous System Diseases.

Browse Nervous System Diseases studies →

Lead sponsor

University Hospital, Grenoble is the lead sponsor of 815 studies on the registry; 205 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Volunteers patient
  • Male or female aged over 18 years
  • Registered in the French social security scheme
  • Signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Contraindication to Magnetoencephalography (MEG) and/or Electroencephalography (EEG)
  • Contraindication to Magnetic resonance imaging (MRI)
  • All categories of protected persons
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Patients

    Imaging devices

    Device: Imaging devices

Interventions

  • DeviceImaging devices

    technological adjustment tests

06

What researchers measure

Primary outcomes

  1. Magnetic brain activity

    MEG records

    Time frame: 2 hours

  2. Brain imaging

    MRI and SPECT-CT records

    Time frame: 2 hours

  3. Electrical brain activity

    EEG records

    Time frame: 2 hours

  4. Motor activity parameters

    Motor platform records

    Time frame: 2 hours

07

Study locations

1 site
  • CLINATEC
    Grenoble, 38000, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02790424
Lead sponsor
University Hospital, Grenoble
Responsible party
Sponsor
First posted
Jun 3, 2016
Start date
Oct 22, 2013
Primary completion
Oct 22, 2021
Completion
Oct 22, 2021
Last update
Nov 14, 2022

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Nervous System Diseases→

Other studies from this sponsor

University Hospital, Grenoble

Start the discussion